Infectious diseases such as HIV and HBV are a global concern for their impact in terms of public health and costs for national health services. A central role in contrasting the spread of the infections is represented by timely diagnosis. The speed of detection depends on several factors including the type of test used. Antibody response to hepatitis B surface antigens (anti-HBs) is an important serological marker used for HBV-infection detection. The aim of this study was to compare the performance of the Abbott system and of the new analyser Mindray 1200i in the detection of HBV- and HIV-infections. Clinical serum samples were collected from patients randomly selected from PTV University Hospital of University of Rome "Tor Vergata" and tested for HBV and HIV antibodies. Samples were evaluated by Mindray Cl 1200i CLIA screening tests for HBV and HIV and the results were compared with the Abbott Architect analytical system, the routine instrument of the hospital clinical biochemistry laboratory. Precision study, linearity, and carryover were performed on the results obtained. The agreement between the results of the Abbott and Mindray CLIA ranged from 99% to 100% and the discrepancy rate from 0% to 1%. The measurements demonstrated that the Mindray CL-1200i platform offers high-level performance with accurate and consistent test results and could represent a valuable tool if implemented in routine analysis.

Nicolai, E., Sarubbi, S., Pelagalli, M., Basile, V., Terrinoni, A., Minieri, M., et al. (2023). Performance Evaluation of the New Chemiluminescence Immunoassay CL-1200i for HBV, HIV Panels. DISEASES, 11(2), 83 [10.3390/diseases11020083].

Performance Evaluation of the New Chemiluminescence Immunoassay CL-1200i for HBV, HIV Panels

Nicolai, Eleonora;Terrinoni, Alessandro;Minieri, Marilena;Grelli, Sandro;Bernardini, Sergio;Pieri, Massimo
2023-06-08

Abstract

Infectious diseases such as HIV and HBV are a global concern for their impact in terms of public health and costs for national health services. A central role in contrasting the spread of the infections is represented by timely diagnosis. The speed of detection depends on several factors including the type of test used. Antibody response to hepatitis B surface antigens (anti-HBs) is an important serological marker used for HBV-infection detection. The aim of this study was to compare the performance of the Abbott system and of the new analyser Mindray 1200i in the detection of HBV- and HIV-infections. Clinical serum samples were collected from patients randomly selected from PTV University Hospital of University of Rome "Tor Vergata" and tested for HBV and HIV antibodies. Samples were evaluated by Mindray Cl 1200i CLIA screening tests for HBV and HIV and the results were compared with the Abbott Architect analytical system, the routine instrument of the hospital clinical biochemistry laboratory. Precision study, linearity, and carryover were performed on the results obtained. The agreement between the results of the Abbott and Mindray CLIA ranged from 99% to 100% and the discrepancy rate from 0% to 1%. The measurements demonstrated that the Mindray CL-1200i platform offers high-level performance with accurate and consistent test results and could represent a valuable tool if implemented in routine analysis.
8-giu-2023
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/07 - MICROBIOLOGIA E MICROBIOLOGIA CLINICA
English
HBV detection
HIV detection
chemiluminescence immunoassay
Nicolai, E., Sarubbi, S., Pelagalli, M., Basile, V., Terrinoni, A., Minieri, M., et al. (2023). Performance Evaluation of the New Chemiluminescence Immunoassay CL-1200i for HBV, HIV Panels. DISEASES, 11(2), 83 [10.3390/diseases11020083].
Nicolai, E; Sarubbi, S; Pelagalli, M; Basile, V; Terrinoni, A; Minieri, M; Cennamo, O; Grelli, S; Bernardini, S; Pieri, M
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
diseases-11-00083-v2.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 553.17 kB
Formato Adobe PDF
553.17 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/332483
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact